Francesca Lim

1.0k total citations
49 papers, 350 citations indexed

About

Francesca Lim is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Francesca Lim has authored 49 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 9 papers in Surgery. Recurrent topics in Francesca Lim's work include CAR-T cell therapy research (17 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Francesca Lim is often cited by papers focused on CAR-T cell therapy research (17 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Francesca Lim collaborates with scholars based in Singapore, United States and United Kingdom. Francesca Lim's co-authors include Chin Hur, William Ying Khee Hwang, Jennifer A. Woo Baidal, Brandon K. Bellows, Brianna N. Lauren, Adam S. Faye, Yunxin Chen, Eunah Lee, Aloysius Ho and Walter Barberi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Francesca Lim

42 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Lim Singapore 12 138 75 62 57 41 49 350
Gülsan Yavuz Türkiye 12 78 0.6× 40 0.5× 69 1.1× 77 1.4× 49 1.2× 45 324
Kathleen M.M. Vanni United States 16 100 0.7× 52 0.7× 60 1.0× 50 0.9× 66 1.6× 41 557
Orhan Türken Türkiye 9 157 1.1× 70 0.9× 87 1.4× 35 0.6× 65 1.6× 32 491
Roberta Della Pepa Italy 12 110 0.8× 69 0.9× 45 0.7× 109 1.9× 65 1.6× 35 367
Yijin Gao China 13 133 1.0× 76 1.0× 52 0.8× 40 0.7× 31 0.8× 66 511
Rita Balter Italy 12 115 0.8× 66 0.9× 46 0.7× 71 1.2× 55 1.3× 36 361
Michelle E A Borm Netherlands 11 138 1.0× 131 1.7× 109 1.8× 32 0.6× 68 1.7× 25 459
Philipp Hofer Austria 11 70 0.5× 84 1.1× 67 1.1× 54 0.9× 31 0.8× 26 490
Hisanori Nakayama Japan 11 104 0.8× 61 0.8× 56 0.9× 32 0.6× 26 0.6× 17 439
Mary Taj United Kingdom 13 219 1.6× 41 0.5× 36 0.6× 125 2.2× 60 1.5× 29 550

Countries citing papers authored by Francesca Lim

Since Specialization
Citations

This map shows the geographic impact of Francesca Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Lim more than expected).

Fields of papers citing papers by Francesca Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Lim. The network helps show where Francesca Lim may publish in the future.

Co-authorship network of co-authors of Francesca Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Lim. A scholar is included among the top collaborators of Francesca Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Lim. Francesca Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seng, Michaela Su-Fern, Shui Yen Soh, Francesca Lim, et al.. (2025). Manufacturing Characteristics and Early Outcomes of a Tandem aCD22-aCD19 CAR-T Therapy for Childhood and Adult Relapsed/Refractory Acute Precursor B Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 31(2). S11–S11. 1 indexed citations
2.
Tong, Louis, Yu‐Chi Liu, Sharon Yeo, et al.. (2025). Tear Cytokine Changes up to One Year After Allogeneic Hematopoietic Stem Cell Transplant: Effect of Daily Topical Cyclosporine-A 0.1% Emulsion. International Journal of Molecular Sciences. 26(12). 5915–5915.
3.
Lim, Nicole-Ann, Yang Sun, Jing Yuan Tan, et al.. (2025). Outcomes in relapsed/refractory diffuse large B-cell lymphoma in an Asian tertiary cancer center: real-world interventions as benchmark for novel therapy. SHILAP Revista de lepidopterología. 10. 100195–100195.
4.
Zeming, Kerwin Kwek, Ka‐Wai Cheung, Elizabeth Lee, et al.. (2025). Cell trajectory modulation: rapid microfluidic biophysical profiling of CAR T cell functional phenotypes. Nature Communications. 16(1). 4775–4775.
5.
Wu, Xiaolin, Francesca Lim, Yie Hou Lee, et al.. (2024). A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells. Nature Biomedical Engineering. 8(12). 1571–1591. 22 indexed citations
6.
Chan, Cheryl, J. Loh, Chandramouli Nagarajan, et al.. (2024). Extracellular viral microRNAs as biomarkers of virus infection in human cells. Molecular Therapy — Nucleic Acids. 36(1). 102444–102444.
7.
Rubenstein, Joel H., Jennifer Burns, Marilla A. Opra Widerquist, et al.. (2023). Yield of Repeat Endoscopy for Barrett's Esophagus After Normal Index Endoscopy. The American Journal of Gastroenterology. 118(7). 1168–1174. 2 indexed citations
8.
Sheng, Jennifer, Jing Tan, Yeh Hong Tan, et al.. (2023). 335MO Real-world outcomes of diffuse large B cell lymphoma treated with R-CHOP(-like) therapy in an Asian multi-ethnic population. Annals of Oncology. 34. S1601–S1601. 1 indexed citations
9.
Ong, Shin Yeu, et al.. (2023). Current perspectives on resistance to chimeric antigen receptor T‐cell therapy and strategies to improve efficacy in B‐cell lymphoma. European Journal Of Haematology. 112(2). 144–152. 2 indexed citations
10.
Chan, Jason Yongsheng, Nagavalli Somasundaram, Nicholas F. Grigoropoulos, et al.. (2023). Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations. Discover Oncology. 14(1). 132–132. 9 indexed citations
11.
Lim, Francesca, et al.. (2023). Quantifying the potential benefits of early detection for pancreatic cancer through a counterfactual simulation modeling analysis. Scientific Reports. 13(1). 20028–20028. 2 indexed citations
12.
Poon, Michelle, Jan Walewski, Isidro Jarque, et al.. (2023). ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2. Hematological Oncology. 41(S2). 141–142. 5 indexed citations
13.
Lim, Francesca, et al.. (2022). A unique hub‐and‐spoke model to optimize patient management in lymphoma using novel CAR‐T cell therapy in Southeast and South Asia. Hematological Oncology. 40(S1). 4–12. 5 indexed citations
14.
Lee, Eunah, Francesca Lim, Adam S. Faye, Bo Shen, & Chin Hur. (2022). Endoscopic Balloon Dilation Is Cost-Effective for Crohn’s Disease Strictures. Digestive Diseases and Sciences. 67(12). 5462–5471. 11 indexed citations
15.
Laszkowska, Monika, et al.. (2022). Heightened Risk for Gastric Cancer Among Immigrant Populations in New York State From High-Incidence Countries. Clinical Gastroenterology and Hepatology. 21(10). 2673–2675.e3. 3 indexed citations
16.
Lim, Francesca, Jennifer S. Ferris, Susan E. Bates, et al.. (2022). Cost-effectiveness of universal screening for germline BRCA mutations in metastatic pancreatic cancer.. Journal of Clinical Oncology. 40(4_suppl). 536–536.
17.
Lee, Eunah, Francesca Lim, Jean‐Frédéric Colombel, Chin Hur, & Adam S. Faye. (2021). Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 28(8). 1169–1176. 7 indexed citations
18.
Daher, May, Rafet Başar, Hila Shaim, et al.. (2017). The TGF-β/SMAD Signaling Pathway As a Mediator of NK Cell Dysfunction and Immune Evasion in Myelodysplastic Syndrome. Blood. 130. 53–53. 17 indexed citations
19.
Diong, Colin Phipps, S. Gopalakrishnan, Aloysius Ho, et al.. (2016). An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication. Bone Marrow Transplantation. 52(3). 363–371. 3 indexed citations
20.
Lim, Francesca, et al.. (2010). Cutaneous follicular hyperkeratotic spicules – the first clinical sign of multiple myeloma progression or relapse. International Journal of Dermatology. 49(8). 934–936. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gülsan Yavuz Breakdown of academic impact, for papers by Kathleen M.M. Vanni Breakdown of academic impact, for papers by Orhan Türken Breakdown of academic impact, for papers by Roberta Della Pepa Breakdown of academic impact, for papers by Yijin Gao Breakdown of academic impact, for papers by Rita Balter Breakdown of academic impact, for papers by Michelle E A Borm Breakdown of academic impact, for papers by Philipp Hofer Breakdown of academic impact, for papers by Hisanori Nakayama Breakdown of academic impact, for papers by Mary Taj
Rankless by CCL
2026